Compare Medipal Holdings Corp. with Similar Stocks
Dashboard
1
Weak Long Term Fundamental Strength with a 6.11% CAGR growth in Operating Profits over the last 5 years
2
Poor long term growth as Net Sales has grown by an annual rate of 3.31% and Operating profit at 6.11% over the last 5 years
3
Flat results in Jun 26
4
With ROE of 8.66%, it has a expensive valuation with a 0.88 Price to Book Value
5
Underperformed the market in the last 1 year
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
21.0%
0%
21.0%
6 Months
9.59%
0%
9.59%
1 Year
20.44%
0%
20.44%
2 Years
24.72%
0%
24.72%
3 Years
22.78%
0%
22.78%
4 Years
74.45%
0%
74.45%
5 Years
44.87%
0%
44.87%
Medipal Holdings Corp. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
3.31%
EBIT Growth (5y)
6.11%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.42
Sales to Capital Employed (avg)
5.92
Tax Ratio
35.07%
Dividend Payout Ratio
31.93%
Pledged Shares
0
Institutional Holding
0.07%
ROCE (avg)
14.57%
ROE (avg)
8.85%
Valuation key factors
Factor
Value
P/E Ratio
10
Industry P/E
Price to Book Value
0.88
EV to EBIT
5.41
EV to EBITDA
4.02
EV to Capital Employed
0.79
EV to Sales
0.08
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
14.62%
ROE (Latest)
8.66%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
Bearish
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
Bullish
Bullish
OBV
No Trend
Bullish
Shareholding Snapshot : Jun 2026
Shareholding Compare (%holding) 
Majority shareholders
Foreign Institutions
Domestic Funds
Held in 0 Schemes (0%)
Foreign Institutions
Held by 1 Foreign Institutions (0.0%)
Strategic Entities with highest holding
Highest Public shareholder
Quarterly Results Snapshot (Consolidated) - Jun'26 - YoY
Jun'26
Jun'25
Change(%)
Net Sales
989,503.00
945,159.00
4.69%
Operating Profit (PBDIT) excl Other Income
18,089.00
18,636.00
-2.94%
Interest
3.00
3.00
Exceptional Items
-410.00
-450.00
8.89%
Consolidate Net Profit
15,942.00
12,612.00
26.40%
Operating Profit Margin (Excl OI)
13.50%
14.90%
-0.14%
USD in Million.
Net Sales
YoY Growth in quarter ended Jun 2026 is 4.69% vs 3.94% in Jun 2025
Consolidated Net Profit
YoY Growth in quarter ended Jun 2026 is 26.40% vs 5.04% in Jun 2025
Annual Results Snapshot (Consolidated) - Mar'26
Mar'26
Mar'25
Change(%)
Net Sales
3,817,354.00
3,671,328.00
3.98%
Operating Profit (PBDIT) excl Other Income
71,834.00
74,028.00
-2.96%
Interest
13.00
7.00
85.71%
Exceptional Items
-15,043.00
-117.00
-12,757.26%
Consolidate Net Profit
53,141.00
51,530.00
3.13%
Operating Profit Margin (Excl OI)
13.90%
15.10%
-0.12%
USD in Million.
Net Sales
YoY Growth in year ended Mar 2026 is 3.98% vs 3.16% in Mar 2025
Consolidated Net Profit
YoY Growth in year ended Mar 2026 is 3.13% vs -0.46% in Mar 2025
About Medipal Holdings Corp. 
Medipal Holdings Corp.
Retailing
No Details Available.
Company Coordinates 
No Company Details Available
Footer loading






